Navigating Barriers and Opportunities: Perceptions of the Non-Occupational Post-Exposure Prophylaxis Care Continuum Among Young Sexual Minority Men, Aged 17-24, in the United States
- PMID: 38864761
- PMCID: PMC11301707
- DOI: 10.1089/apc.2024.0012
Navigating Barriers and Opportunities: Perceptions of the Non-Occupational Post-Exposure Prophylaxis Care Continuum Among Young Sexual Minority Men, Aged 17-24, in the United States
Abstract
Human immunodeficiency virus (HIV) is a public health concern among young sexual minority men (YSMM), ages 17 to 24, in the United States. Biomedical prevention methods, such as pre-exposure prophylaxis (PrEP) and non-occupational post-exposure prophylaxis (nPEP), can help reduce the risk of HIV transmission among this population. However, there is limited awareness and use of nPEP by YSMM. This study aims to explore the perceptions of YSMM regarding the nPEP care continuum, which consists of three areas of focus: awareness, uptake, and linkage to other HIV prevention services. This study draws on synchronous online focus groups with a sample of 41 YSMM in the United States. Transcripts from the focus groups were analyzed using reflexive thematic analysis. Participants reported limited nPEP awareness and prior use, a process of personal appraisal of nPEP need based on HIV risk and costs, and a preference for PrEP over PEP for long-term HIV prevention. Interventions should be tailored to increase awareness of nPEP among YSMM and reduce addressable barriers to nPEP use for YSMM, including cost and confidentiality concerns, in situations where nPEP is warranted. Finally, more research is needed on how nPEP use can act as a bridge to PrEP initiation for this population.
Keywords: human immunodeficiency virus; non-occupational post-exposure prophylaxis; synchronous online focus groups; young sexual minority men.
References
-
- Dominguez KL, Smith DK, Vasavi Thomas, et al. Updated guidelines for antiretroviral postexposure prophylaxis after sexual, injection drug use, or other nonoccupational exposure to HIV—United States, 2016. 2018. - PubMed
-
- Centers for Disease Control and Prevention. Diagnoses of HIV Infection in the United States and Dependent Areas, 2021. HIV Surveill Rep 2022;33.
-
- Smith DK, Grohskopf LA, Black RJ, et al. Antiretroviral postexposure prophylaxis after sexual, injection-drug use, or other nonoccupational exposure to HIV in the United States. Morb Mortal Wkly Rep Recomm Rep 2005;54(2):1–20. - PubMed
-
- John SA, Sizemore KM, Jimenez RH, et al. The use of HIV pre- and postexposure prophylaxis among a web-based sample of HIV-negative and unknown status cisgender and transgender sexual minority men: Cross-sectional study. JMIR Public Health Surveill 2022;8(12):e31237; doi: 10.2196/31237 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
